{
  "Figure": "nihms781581_page11_322.jpg",
  "Figure_title": "Figure 2.  Kaplan-Meier estimates of progression free survival (PFS) in (A) intent-to-treat, (B) EGFR  wild type, (C) elevated baseline PGEM, (D) low baseline PGEM. HR, hazard ratio; PGEM,  urine prostaglandin E metabolite. "
}